Drug intelligence / Profile preview

YIYANG TangLv milk powder

Development stage: Unknown
Lead developer: Nestlé

Overview

YIYANG TangLv is a functional milk powder developed by Nestlé (Société des Produits Nestlé) designed to manage post-prandial glucose levels. It is formulated with mulberry leaf extract, vegetable oil, and inulin. The primary active component, mulberry leaf extract, contains 1-deoxynojirimycin (DNJ), which acts as an alpha-glucosidase inhibitor. By inhibiting this enzyme in the small intestine, the product slows the breakdown of complex carbohydrates into simple sugars, thereby reducing the early postprandial glucose and insulin responses. It is marketed in China as a nutritional intervention for healthy and pre-diabetic adults to support blood glucose management.

Brand names: YIYANG TangLv
Other names: blood collection-Société des Produits Nestlé (SPN)Nestle YIYANG TangLv milk powder

Targets

Sucrase-Isomaltase

Beyond the preview

Go deeper on YIYANG TangLv milk powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YIYANG TangLv milk powder.

Explore the full profile